Washington
+919359902383
+919359902383
Antibiotic Medicine

Imipenem & Cilastatin 1g Injection Exporter from India to USA, UK, Australia, Singapore, Thailand, and Jamaica | Premium Carbapenem Antibiotic Supplier | Ernest Impex Global Medicine Logistics

In stockcod not available
Phone Number

+919359902383

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Washington D.C., DC, USA

Washington, United States, 20001

Description

Extensive Product Profile: Understanding Imipenem and Cilastatin for Injection 1 g Imipenem and Cilastatin for Injection 1 g is a powerful, broad-spectrum carbapenem antibiotic combination. It is a sterile, pyrogen-free formulation comprising two active components: Imipenem, a potent thienamycin antibacterial agent, and Cilastatin sodium, a reversible inhibitor of the renal enzyme dehydropeptidase I. This synergistic combination is utilized in clinical settings to manage severe, complicated bacterial infections where a high level of bactericidal activity is required. 1. Clinical Indications & Usage This combination therapy is reserved for the treatment of serious infections caused by susceptible organisms, particularly in hospital environments. Key clinical indications include: Lower Respiratory Tract Infections: Management of severe pneumonia and infected bronchiectasis. Urinary Tract Infections (UTIs): Treatment of complicated infections, including pyelonephritis. Intra-Abdominal Infections: Used in the management of peritonitis, complicated appendicitis, and other intra-abdominal abscesses. Gynecological Infections: Indicated for postpartum infections and severe endometritis. Skin and Soft Tissue Infections: Management of severe infections, including those occurring in diabetic patients or wound complications. Bone and Joint Infections: Used for the treatment of osteomyelitis and septic arthritis. Systemic Infections: Management of septicemia, endocarditis, and serious infections in immunocompromised patients (e.g., febrile neutropenia). 2. Mechanism of Action Imipenem: Acts as a bactericidal agent by binding to specific Penicillin-Binding Proteins (PBPs), primarily PBP 2, PBP 3, and PBP 4, in the bacterial cell wall. This binding inhibits peptidoglycan synthesis, leading to rapid cell wall lysis and bacterial death. Cilastatin: This component provides no antibacterial effect itself. However, it acts as a highly specific, reversible inhibitor of the enzyme dehydropeptidase I, which is found in the renal brush border. Imipenem is normally metabolized by this enzyme in the kidneys; by inhibiting it, cilastatin prevents the inactivation of imipenem, ensuring higher, sustained therapeutic levels in the bloodstream and reducing potential renal accumulation. 3. Administration and Dosing Route: This medication is formulated as a sterile powder for reconstitution and must be administered strictly by intravenous (IV) infusion. Preparation: Reconstitution must be performed using compatible IV diluents (e.g., 0.9% Sodium Chloride) under aseptic conditions to maintain sterility and potency. Dosing Guidelines: The dosage and frequency are strictly determined by a physician based on the infection site, the severity of the illness, the patient's body weight, and renal function. It is typically administered every 6 to 8 hours. ⚠️ Safety, Side Effects, and Monitoring Hypersensitivity: Contraindicated in patients with a history of severe hypersensitivity or anaphylaxis to any carbapenem or beta-lactam antibiotic. Neurological Safety: While rare, carbapenems can cause central nervous system (CNS) adverse events, including tremors or seizures. Clinical caution is necessary for patients with a history of CNS disorders or renal impairment. Common Side Effects: Observed clinical side effects include nausea, vomiting, diarrhea, skin rash, and local reactions at the intravenous injection site (such as phlebitis or thrombophlebitis). Monitoring: Clinicians must monitor for the emergence of superinfections, particularly Clostridioides difficile-associated diarrhea, and perform ongoing assessment of renal function to ensure appropriate dosage. 📦 Storage and Handling Storage Framework: Keep vials stored in their original packaging at controlled room temperature (20°C to 25°C). The product must be kept in a dry, dark place protected from excessive heat and moisture. Stability: The reconstituted solution should be used according to validated clinical stability protocols to ensure the injection remains sterile and fully potent. PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: This profile is compiled for medical professional information and clinical research. Imipenem and Cilastatin for Injection 1 g is a prescription-only medication and must be administered strictly under the supervision of a licensed physician or within a professional hospital setting. Use during pregnancy or while breastfeeding should only occur if the potential clinical benefit justifies the potential risk to the patient and fetus. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Keywords

Other Products

view all

68179d65be22ee500d53ff54 Card 2

product image
Male Hormones

Extensive Product Profile: Understanding Clenbut 40 (Clenbuterol Hydrochloride 40 mcg) Clenbut 40 contains Clenbuterol Hydrochloride, a sympathomimetic amine classified as a selective beta-2 adrenergic agonist. While recognized for its historical use in specific therapeutic areas, it is a potent pharmacological agent that acts directly on the beta-2 receptors in the body, primarily affecting smooth muscle tissue. 1. Mechanism of Action Clenbuterol Hydrochloride functions through targeted adrenergic stimulation: Beta-2 Adrenergic Agonism: It acts as a selective agonist at beta-2 adrenergic receptors. By stimulating these receptors, it triggers the production of cyclic AMP (cAMP) via the activation of adenyl cyclase. Smooth Muscle Relaxation: Activation of these receptors leads to the relaxation of smooth muscles, particularly in the bronchial tree, which has historically facilitated its use in managing respiratory distress associated with airway obstruction. Metabolic Effects: Through the stimulation of beta-adrenergic receptors, the compound can influence metabolic processes, including thermogenesis and glycogenolysis, which significantly alters physiological energy expenditure. 2. Clinical and Physiological Profile Primary Action: Clenbuterol is highly selective for beta-2 receptors compared to beta-1 receptors, which theoretically minimizes stimulation of the heart compared to non-selective agents; however, cardiovascular side effects remain a significant concern due to systemic absorption. Systemic Interaction: Because beta-adrenergic receptors are distributed throughout various organ systems, the administration of Clenbuterol induces systemic effects beyond its primary site of action, impacting the central nervous system, cardiovascular system, and skeletal muscle tissue. 3. Safety, Side Effects, and Monitoring Clenbuterol is a potent compound requiring cautious handling and strict adherence to medical guidance: Cardiovascular Risks: Common adverse effects include tachycardia (rapid heart rate), palpitations, and arrhythmias. Prolonged use or excessive dosage can lead to cardiac hypertrophy (enlargement of the heart muscle). Neurological Effects: Patients may experience tremors (particularly in the hands), nervousness, restlessness, anxiety, and insomnia. Metabolic Disturbances: Potential for electrolyte imbalances, such as hypokalemia (low potassium levels), which can further exacerbate cardiac risk. Additional Concerns: Users may report headache, nausea, excessive sweating, and muscle cramps. Due to the risk of cardiac and systemic toxicity, regular monitoring of blood pressure, heart rate, and electrolyte levels is essential in any clinical setting. 📦 Storage and Handling Specifications Storage Framework: Store Clenbut 40 tablets in a cool, dry place at controlled room temperature (typically 20°C to 25°C). Environmental Safeguards: Keep the tablets in their original, light-resistant packaging. Protect from excessive moisture, heat, and direct sunlight. Keep strictly out of reach of children and domestic pets. PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: This profile is compiled for educational and clinical research purposes only. Clenbuterol Hydrochloride 40 mcg is a potent pharmacological agent. It must be used only under the direct supervision of a licensed healthcare professional. Improper use, particularly at supratherapeutic doses, poses severe risks to cardiovascular health. It is not approved for use in pregnancy and breastfeeding is contraindicated. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
sedative-hypnotic

Product Profile: Zopicol 7.5 mg Zopicol 7.5 mg contains Zopiclone, a non-benzodiazepine hypnotic agent from the cyclopyrrolone class. It is indicated for the short-term management of severe insomnia, helping patients achieve a more regular sleep pattern by inducing sleep and reducing the frequency of nighttime awakenings. 1. Clinical Indications & Usage Insomnia Management: Indicated for the short-term treatment of transient, situational, or chronic insomnia. Therapeutic Goal: Assists in shortening sleep onset latency and improving overall sleep maintenance in adults for whom insomnia is debilitating. 2. Mechanism of Action Zopicol acts as a central nervous system (CNS) depressant: GABA-A Receptor Modulation: It binds selectively to the GABA-A receptor complex, specifically the omega-1 receptor subtype. Sedative Effect: By enhancing the inhibitory effects of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, Zopicol produces sedative, hypnotic, and anxiolytic effects, effectively calming neural activity to facilitate sleep. 3. Administration and Dosing Guide Administration: Take one tablet orally immediately before bedtime. Dosage: The recommended dose for adults is typically 7.5 mg. Due to the rapid onset of action, patients should ensure they have a full 7–8 hour window available for sleep before needing to be active. Duration: Therapy should be as short as possible, generally ranging from a few days to two weeks. Prolonged use is not recommended due to the potential for dependency and tolerance. ⚠️ Safety, Side Effects, and Monitoring Warnings: Zopicol can cause daytime drowsiness, dizziness, or impaired alertness. Avoid operating heavy machinery or driving after ingestion. Contraindications: Do not consume alcohol or other CNS depressants while using Zopicol, as this significantly increases the risk of respiratory depression and excessive sedation. Common Side Effects: A characteristic metallic or bitter taste in the mouth (dysgeusia), dry mouth, drowsiness, headache, and dizziness. Dependency Risk: Long-term use or abrupt discontinuation may lead to withdrawal symptoms or rebound insomnia. Tapering under medical supervision is often required. 📦 Storage, Stability & Commercial Packaging Storage Environment: Store in a cool, dry place (below 30°C/86°F). Protection: Maintain in original manufacturer’s blister packaging to protect from light and atmospheric moisture. Safety: Must be kept strictly out of the reach of children, as accidental ingestion can be dangerous. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Zopicol 7.5 mg is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] Connect with our global trade desk for procurement inquiries, commercial documentation, and supply chain logistics: 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
Antibiotic Medicine

Extensive Product Profile: Understanding Imipenem and Cilastatin for Injection 1 g Imipenem and Cilastatin for Injection 1 g is a powerful, broad-spectrum carbapenem antibiotic combination. It is a sterile, pyrogen-free formulation comprising two active components: Imipenem, a potent thienamycin antibacterial agent, and Cilastatin sodium, a reversible inhibitor of the renal enzyme dehydropeptidase I. This synergistic combination is utilized in clinical settings to manage severe, complicated bacterial infections where a high level of bactericidal activity is required. 1. Clinical Indications & Usage This combination therapy is reserved for the treatment of serious infections caused by susceptible organisms, particularly in hospital environments. Key clinical indications include: Lower Respiratory Tract Infections: Management of severe pneumonia and infected bronchiectasis. Urinary Tract Infections (UTIs): Treatment of complicated infections, including pyelonephritis. Intra-Abdominal Infections: Used in the management of peritonitis, complicated appendicitis, and other intra-abdominal abscesses. Gynecological Infections: Indicated for postpartum infections and severe endometritis. Skin and Soft Tissue Infections: Management of severe infections, including those occurring in diabetic patients or wound complications. Bone and Joint Infections: Used for the treatment of osteomyelitis and septic arthritis. Systemic Infections: Management of septicemia, endocarditis, and serious infections in immunocompromised patients (e.g., febrile neutropenia). 2. Mechanism of Action Imipenem: Acts as a bactericidal agent by binding to specific Penicillin-Binding Proteins (PBPs), primarily PBP 2, PBP 3, and PBP 4, in the bacterial cell wall. This binding inhibits peptidoglycan synthesis, leading to rapid cell wall lysis and bacterial death. Cilastatin: This component provides no antibacterial effect itself. However, it acts as a highly specific, reversible inhibitor of the enzyme dehydropeptidase I, which is found in the renal brush border. Imipenem is normally metabolized by this enzyme in the kidneys; by inhibiting it, cilastatin prevents the inactivation of imipenem, ensuring higher, sustained therapeutic levels in the bloodstream and reducing potential renal accumulation. 3. Administration and Dosing Route: This medication is formulated as a sterile powder for reconstitution and must be administered strictly by intravenous (IV) infusion. Preparation: Reconstitution must be performed using compatible IV diluents (e.g., 0.9% Sodium Chloride) under aseptic conditions to maintain sterility and potency. Dosing Guidelines: The dosage and frequency are strictly determined by a physician based on the infection site, the severity of the illness, the patient's body weight, and renal function. It is typically administered every 6 to 8 hours. ⚠️ Safety, Side Effects, and Monitoring Hypersensitivity: Contraindicated in patients with a history of severe hypersensitivity or anaphylaxis to any carbapenem or beta-lactam antibiotic. Neurological Safety: While rare, carbapenems can cause central nervous system (CNS) adverse events, including tremors or seizures. Clinical caution is necessary for patients with a history of CNS disorders or renal impairment. Common Side Effects: Observed clinical side effects include nausea, vomiting, diarrhea, skin rash, and local reactions at the intravenous injection site (such as phlebitis or thrombophlebitis). Monitoring: Clinicians must monitor for the emergence of superinfections, particularly Clostridioides difficile-associated diarrhea, and perform ongoing assessment of renal function to ensure appropriate dosage. 📦 Storage and Handling Storage Framework: Keep vials stored in their original packaging at controlled room temperature (20°C to 25°C). The product must be kept in a dry, dark place protected from excessive heat and moisture. Stability: The reconstituted solution should be used according to validated clinical stability protocols to ensure the injection remains sterile and fully potent. PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: This profile is compiled for medical professional information and clinical research. Imipenem and Cilastatin for Injection 1 g is a prescription-only medication and must be administered strictly under the supervision of a licensed physician or within a professional hospital setting. Use during pregnancy or while breastfeeding should only occur if the potential clinical benefit justifies the potential risk to the patient and fetus. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383